Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
4.710
+0.040 (0.86%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $694.59 million as of October 29, 2024. Its market cap has increased by 12.07% in one year.
Market Cap
694.59M
Enterprise Value
628.80M
1-Year Change
12.07%
Ranking
Category
Stock Price
$4.71
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.88B to $694.59M, a decrease of -85.75%. That is a compound annual growth rate of -30.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 688.70M | -2.92% |
| Dec 29, 2023 | 709.40M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | 8.09B | 117.39% |
| Dec 31, 2019 | 3.72B | -23.69% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 713.77M |
| Opthea | 713.63M |
| Oculis Holding AG | 711.76M |
| Tourmaline Bio | 697.96M |
| Mineralys Therapeutics | 681.26M |
| Humacyte | 679.55M |
| Ironwood Pharmaceuticals | 674.90M |
| Olema Pharmaceuticals | 672.12M |